The study of correlation of bmi and blood pressure in young healthy medical students

Background: The widely reported associations between body mass index (BMI) and various chronic diseases, such as hypertension and coronary heart diseases have garnered significant attention. Nonetheless, there remains a dearth of research dedicated to understanding the health impacts of medical college on the students, who experience considerable academic pressure. In that context, this study was driven by the goal of investigating the intricate interplay between BMI, blood pressure (BP) among medical students. Blood pressure (BP) has been found to rise among populations due to the high body mass index (BMI). Overweight and persons who have high BP are prone to develop heart diseases. The objective of this study was to evaluate the correlation between BMI and BP among medical students in both males and females aged 18 years and above. Methods: 120 medical students were enrolled in the study. BMI (Kg/m2) and blood pressure (mmHg) were measured. The data was analysed using appropriate statistical tests. Results: The mean value of systolic blood pressure in normal weight participants was 111.70±3.34, the mean value in overweight was 114.10±3.78 and in obese volunteers the mean value was 126.90 ±5.04. It was observed that as the weight goes on increasing the BP also increases and was statistically significant. The mean value of diastolic blood pressure in normal weight was 70.10 ± 1.75, the mean value in over weight was 75.60 ±1.51 and in obese the mean value was 85.60 ±5.67 which was found to be increased in obese. The p value was <0.001 hence statistically significant. In our study significant increase in pulse rate, systolic blood pressure and diastolic blood pressure was observed in overweight and obese as compared to normal weight. Conclusions: BMI demonstrated a notably strong positive correlation with both diastolic BP and systolic BP. Therefore, for medical students as well as the daily health care of patients, weight control is recommended to better combat obesity-related diseases, for example, cardiovascular diseases, hypertension and dyslipideamia.